Systemic anticancer therapy near the end of life: an analysis of factors influencing treatment in advanced tumor disease
The timing of SACT near the EOL is significantly influenced by several factors, including the type of SACT, referral to PC services, admission to PC unit, and ECOG performance status. These findings underscore the complexity of treatment decisions in advanced cancer care and highlight the need for personalized, patient-centered approaches that consider both clinical and patient-related factors to optimize care at the EOL.
Authors
- Klaus Hackner (ORCID: https://orcid.org/0000-0002-6378-5840)
- Josef Singer (ORCID: https://orcid.org/0000-0002-8701-2412)
- Franziska Jutz (ORCID: https://orcid.org/0000-0002-0260-8576)
- Ayça Zeybek
- Iris Groissenberger
- Gudrun Kreye (ORCID: https://orcid.org/0000-0003-0674-7079)
- Lisa Tschurlovich
- J Schediwy
- Sandra Gottsauner-Wolf
- N-S Le
Institutions
- Zug Cantonal Hospital (CH)
- Karl Landsteiner University of Health Sciences (AT)
Publication Details
- Journal
- ESMO Open
- Published
- 2024-08-29
- DOI
- https://doi.org/10.1016/j.esmoop.2024.103683
- Citations
- 12
- Primary Topic
- Economic and Financial Impacts of Cancer
- Type
- article
- Field-Weighted Citation Impact
- 13.55
Funders
- Amgen
- AstraZeneca
- Karl Landsteiner Privatuniversität für Gesundheitswissenschaften